Table 4. Multivariate analysis for overall mortality.
| NSTEMI | Adjusted OR | 95% CI | p-value | |
|---|---|---|---|---|
| Lower | Upper | |||
| Age | 1.045 | 1.034 | 1.057 | <0.001 |
| Killip classification | 1.334 | 1.213 | 1.468 | <0.001 |
| CKD | 1.335 | 1.046 | 1.703 | 0.020 |
| Cerebrovascular disease | 1.421 | 1.031 | 1.959 | 0.032 |
| Use of b-blocker | 0.405 | 0.322 | 0.511 | <0.001 |
| Use of ACE inhibitor/ARB | 0.446 | 0.355 | 0.559 | <0.001 |
| Use of statin | 0.170 | 0.133 | 0.217 | <0.001 |
| Hb | 0.912 | 0.862 | 0.966 | 0.002 |
| HDL cholesterol | 0.990 | 0.981 | 1.000 | 0.044 |
| Pre-PCI TIMI 0 or 1 | 0.884 | 0.811 | 0.963 | 0.005 |
| LVEF | 0.986 | 0.977 | 0.995 | 0.003 |
OR = odds ratio, CI = confidence interval, CKD = chronic kidney disease, ACE inhibitor = angiotensin-converting enzyme inhibitor, ARB = angiotensin receptor blocker, Hb = hemoglobin, HDL cholesterol = high density lipoprotein cholesterol, TIMI = Thrombolysis In Myocardial Infarction, LVEF = left ventricular ejection fraction. multivariable logistic regression analyses were carried out to identify independent predictors for overall mortality and on the basis of the variables that were significant (P < 0.05) according to univariable logistic regression analysis